Dermalogica AGE Bright Clearing Serum: acne fields and the appearance story

The manufacturer describes AGE Bright Clearing Serum as a two-in-one serum and links the account to breakouts and visible aging. That identifies the particular item being reviewed, rather than a broad Dermalogica clearing collection. Its name is a product identity, not a participant description or a measured account of who benefits. Manufacturer serum record. The two-in-one description also does not mean two independently established outcomes. It explains the breadth of the brand’s account. The record needs separate support for acne-use information and for claims about a brighter or younger-looking appearance, even when both are discussed in one paragraph.

Keeping the full name visible is a useful first step when nearby products discuss related concerns. The version-and-label guide explains how an exact item name prevents a neighboring formula or outcome from completing an otherwise incomplete record.

The manufacturer lists salicylic acid 2% and a complete inactive declaration. The retained December 2024 label supplies a matching complete base. Dermalogica also qualifies its product list by noting package updates. That qualification remains relevant even when the two records examined here agree. Agreement is a documentary finding, not an assay or inspection of every bottle. Manufacturer declaration. Posted ingredients. The agreement can be checked at the level of the whole retained declarations. That is stronger identity information than finding one highlighted ingredient on each page. It still does not specify an amount for every inactive ingredient or prove that all packages share the same current list.

The two-percent comparison examines why active strength alone leaves the rest of a product open. Here, the complete lists provide more detail while preserving the limits of a posted declaration.

The label record uses NDC 68479-184, codes the dosage form as LIQUID and identifies a 30 mL presentation. The manufacturer calls the consumer-facing format a serum. These descriptions can be reported together without treating the coded form as proof of a formula change or correcting the product’s name to match the table. Coded form and package.

A quantity is likewise not a duration or verified supply promise. The supply-term guide keeps those commercial questions separate. No current price, inventory or delivery was freshly tested for this serum review.

The product discussion names niacinamide, White Shiitake and resurrection-plant ingredients in connection with brightness or hydration narratives. These descriptions explain what the manufacturer emphasizes. They do not, in the examined account, provide a participant group, comparator or full protocol for a finished-serum outcome. Ingredient and FAQ context. Neither White Shiitake nor a plant description supplies a study population by itself. The relevant missing information is about the finished serum and the stated outcome, not simply whether the named ingredients exist in the advertised formula. The formula list and an outcome report have different jobs.

An ingredient story cannot stand in for every missing study field. The Kate Somerville review offers a separate place to examine how appearance advertising is kept distinct from a named product’s label purpose and complete declaration.

Dermalogica’s FAQ describes a water-like feel and a scent associated with botanical ingredients, alongside no artificial-fragrance positioning. These are source descriptions of the advertised serum. The review does not claim to have smelled it, assessed tackiness or compared its texture with another product. Texture and scent account.

The wording also should not become a universal statement about personal fragrance tolerance. A complete ingredient list and a manufacturer’s sensory description answer different questions. They can be useful together without turning this reading of documents into a firsthand product-experience review.

The manufacturer’s FAQ includes sensitive-skin positioning. The acne label retains drying warnings. Both statements remain visible and attributable: the first is a brand description, while the second is part of the posted drug information. Neither alone provides an individual assurance that the serum will feel comfortable. Manufacturer positioning. Label cautions.

The Murad cleanser review provides another comfort-record question. Its evidence is not transferred here. Patch, application and routine instructions from the source are not reproduced as personal guidance in this review.

FDA explains the distinct roles of active ingredient, purpose, use and inactive fields. The posted serum label contributes acne information in that structure, while the manufacturer supplies a broader appearance narrative. The examined product material did not provide a complete finished-serum clinical report for each appearance statement. FDA field definitions. Manufacturer claim account.

The result is a precise product description, not an empty verdict about all evidence. The complete base, named serum and dated package record can be reported. A study population inferred from AGE, an individual outcome or a clinical superiority conclusion cannot be added from those records.